Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| USNA | USANA HEALTH SCIENCES INC | 2026-04-02 17:25:54 | 17 | 0.1 | 0.59 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| USNA | 0000896264 | USANA HEALTH SCIENCES INC | US90328M1071 | 549300YTURXE814MAH96 | 870500306 | NYSE | 2833 | Medicinal Chemicals & Botanical Products | 0103 | UT | 3838 WEST PARKWAY BLVD. | SALT LAKE CITY | UT | 84120-6336 | UNITED STATES | US | 8019547100 | 3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336 | 3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336 | USANA INC | — | 1992 | Kevin Guest | 1,978 | http://usana.com | 328,000,000 | 18,281,000 | 18,456,935 | Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors. | 2026-04-02 18:22:54 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 328,000,000 | -171,000,000 | -34.2685 | 18,456,935 | -447,591 | -2.3676 |
| 2023 | 499,000,000 | -927,392,900 | -65.0167 | 18,904,526 | -389,806 | -2.0203 |
| 2022 | 1,426,392,900 | 609,328,766 | 74.5754 | 19,294,332 | -1,557,936 | -7.4713 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Walter Noot | Chief Operating Officer | 2024 | 550,300 | 0 | — | 40,557 | 22,075 | 1,438,431 |
| Brent Neidig | Chief Commercial Officer | 2024 | 500,245 | 0 | — | 36,868 | 12,075 | 1,299,581 |
| Jim H. Brown | President, Chief Executive Officer | 2024 | 800,000 | 0 | — | 117,908 | 44,181 | 3,362,107 |
| G. Douglas Hekking | Chief Financial Officer | 2024 | 553,829 | 0 | — | 40,817 | 15,520 | 1,440,953 |
| Joshua Foukas | Chief Legal Officer, General Counsel | 2024 | 487,630 | 0 | — | 35,938 | 13,289 | 1,268,334 |
| Fiscal Year | Employee Count |
|---|---|
| 2026 | 1,570 |
| 2024 | 1,700 |
| 2023 | 1,800 |
| Fiscal Year | 2025 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 925,257,000 | 854,503,000 | 998,601,000 |
| Cost Of Revenue | 200,852,000 | 161,212,000 | 193,890,000 |
| Gross Profit | 724,405,000 | 693,291,000 | 804,711,000 |
| Research And Development Expenses | 10,693,000 | 11,571,000 | 11,563,000 |
| General And Administrative Expenses | 337,372,000 | 263,268,000 | 262,304,000 |
| Operating Expenses | 686,973,000 | 626,967,000 | 697,097,000 |
| Operating Income | 37,432,000 | 66,324,000 | 107,614,000 |
| Net Income | 10,760,000 | 42,030,000 | 69,350,000 |
| Earnings Per Share Basic | 0.58 | 2.2 | 3.6 |
| Earnings Per Share Diluted | 0.58 | 2.19 | 3.59 |
| Weighted Average Shares Outstanding Basic | 18,535,000 | 19,103,000 | 19,254,000 |
| Weighted Average Shares Outstanding Diluted | 18,574,000 | 19,162,000 | 19,310,000 |
| Fiscal Year | 2025 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 158,380,000 | 181,768,000 | 288,420,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | — | — | — |
| Inventories | 102,608,000 | 69,735,000 | 67,089,000 |
| Non Trade Receivables | 1,016,000 | 804,000 | 2,030,000 |
| Other Assets Current | 4,853,000 | 4,808,000 | 7,121,000 |
| Total Assets Current | 288,405,000 | 279,187,000 | 384,382,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 94,383,000 | 94,565,000 | 97,773,000 |
| Other Assets Non Current | 61,805,000 | 58,806,000 | 54,795,000 |
| Total Assets Non Current | 137,085,000 | 137,841,000 | 197,267,000 |
| Total Assets | 742,915,000 | 748,193,000 | 596,549,000 |
| Accounts Payable | 17,263,000 | 11,984,000 | 11,049,000 |
| Deferred Revenue | 10,640,000 | 12,050,000 | 20,875,000 |
| Short Term Debt | 14,000,000 | 23,000,000 | — |
| Other Liabilities Current | 97,302,000 | 104,641,000 | 132,784,000 |
| Total Liabilities Current | 128,565,000 | 139,625,000 | 143,833,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 23,186,000 | 18,163,000 | 14,173,000 |
| Total Liabilities Non Current | 28,078,000 | 22,236,000 | — |
| Total Liabilities | 156,643,000 | 161,861,000 | — |
| Common Stock | 18,000 | 19,000 | 19,000 |
| Retained Earnings | 465,720,000 | 478,944,000 | 391,636,000 |
| Accumulated Other Comprehensive Income | -16,178,000 | -22,670,000 | -12,787,000 |
| Total Shareholders Equity | 533,104,000 | 532,109,000 | 434,472,000 |
| Fiscal Year | 2025 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 32,562,000 | 14,539,000 | 13,393,000 |
| Share Based Compensation Expense | 13,828,000 | 14,558,000 | 13,331,000 |
| Other Non Cash Income Expense | 2,093,000 | -1,000 | -141,000 |
| Change In Accounts Receivable | — | — | — |
| Change In Inventories | 34,685,000 | 2,118,000 | -21,879,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 5,204,000 | -1,269,000 | -2,656,000 |
| Change In Other Liabilities | -14,218,000 | -6,745,000 | -9,066,000 |
| Cash From Operating Activities | 22,349,000 | 60,992,000 | 103,902,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 13,823,000 | 10,073,000 | 10,400,000 |
| Acquisition Of Business | 0 | 203,336,000 | 6,532,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -10,125,000 | -213,090,000 | -12,370,000 |
| Tax Withholding For Share Based Compensation | 2,347,000 | 3,223,000 | 4,706,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 27,507,000 | 9,444,000 | 25,382,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 26,600,000 | 1,467,000 | 11,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -40,603,000 | 9,553,000 | -30,088,000 |
| Change In Cash | -23,268,000 | -148,738,000 | 47,667,000 |
| Cash At End Of Period | 158,380,000 | 181,768,000 | 288,420,000 |
| Income Taxes Paid | 37,180,000 | 40,470,000 | 45,863,000 |
| Interest Paid | 663,000 | 76,000 | 49,000 |
| Fiscal Year | 2025 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 0.58 | 2.2 | 3.6 |
| Price To Earnings Ratio | 33.5172 | 16.2227 | 14.7778 |
| Earnings Growth Rate | -73.6364 | -38.8889 | -38.8795 |
| Price Earnings To Growth Ratio | -0.4552 | -0.4172 | -0.3801 |
| Book Value Per Share | 31.6305 | 30.6932 | 23.5128 |
| Price To Book Ratio | 0.6146 | 1.1628 | 2.2626 |
| Ebitda | 81,344,000 | 97,320,000 | 128,798,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 32,380,000 | 11,331,000 | 10,721,000 |
| Free Cash Flow | -10,031,000 | 49,661,000 | 93,181,000 |
| Return On Equity | 0.0202 | 0.079 | 0.1596 |
| One Year Beta | 0.8222 | 0.9685 | 0.5276 |
| Three Year Beta | 0.8404 | 0.6535 | 0.779 |
| Five Year Beta | 0.6825 | 0.7911 | 0.753 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| FULLER GILBERT A | Director | 2026-03-20 | 1,058 | D | 0 |
| Benedict Peter | CHIEF INFORMATION OFFICER | 2026-03-03 | 4,553 | D | 0 |
| Armstrong Kathryn Michelle | CHIEF SCIENTIFIC OFFICER | 2026-02-27 | 4,190 | A | 4,838 |
| Armstrong Kathryn Michelle | CHIEF SCIENTIFIC OFFICER | 2026-02-27 | 2,015 | D | 2,823 |
| Armstrong Kathryn Michelle | CHIEF SCIENTIFIC OFFICER | 2026-02-27 | 4,190 | D | 40,592 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 2025-12-31 | 1,811,515 | 92,283 | 19.63 |
| HSBC HOLDINGS PLC | 2025-12-31 | 259,479 | 13,334 | 19.46 |
| Rockefeller Capital Management L.P. | 2025-12-31 | 334 | 17 | 19.6471 |
| Invesco Ltd. | 2025-12-31 | 742,466 | 37,823 | 19.63 |
| Empowered Funds, LLC | 2025-12-31 | 1,186,378 | 60,437 | 19.63 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Global X Funds | 2026-01-31 | Global X Russell 2000 ETF | RSSL | 4,833 | 104,876.1 | 0.0076 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-01-31 | Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 31,737 | 688,692.9 | 0.0257 |
| ProFunds | 2026-01-31 | SMALL-CAP PROFUND SERVICE CLASS | SLPSX | 11 | 238.7 | 0.0032 |
| ProFunds | 2026-01-31 | SMALL-CAP PROFUND INVESTOR CLASS | SLPIX | 11 | 238.7 | 0.0032 |
| ProFunds | 2026-01-31 | ULTRASMALL-CAP PROFUND SERVICE CLASS | UAPSX | 137 | 2,972.9 | 0.0056 |